35 -YEARS- OLD WOMAN WITH HYDROPNEUMOTHORAX FOLLOWING HEMODIALYSIS ACCESS PLACEMENT IN SEVERE LUPUS NEPHRITIS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/1b0fd5056924af216e8151e954e8fcb2.pdf
35 -YEARS- OLD WOMAN WITH HYDROPNEUMOTHORAX FOLLOWING HEMODIALYSIS ACCESS PLACEMENT IN SEVERE LUPUS NEPHRITIS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
ANDANG
SETIADI
ANDANG SETIADI ANDANG.SETIADI@GMAIL.COM Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia *
Aryo Suseno aryosuseno23@gmail.com Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia -
Ratih Tri Kusuma Dewi ratihsolo@staff.uns.ac.id Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia -
Agung Susanto agungsus08@staff.uns.ac.id Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia -
Bambang Purwanto BAMBANG_P48@STAFF.UNS.AC.ID Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia -
Santy Ayu Puspita Perdhana SANTYAYUPP@GMAIL.COM Sebelas Maret University Faculty of Medicine, Dr. Moewardi Hospital, Surakarta, Central Java Hypertension Renal Division SURAKARTA Indonesia -
-
-
-
-
-
-
-
-
-

Central venous catheterization carries the second highest risk of iatrogenic pneumothorax. Subclavian catheterization carries a higher risk than internal jugular catheterization. Pneumothorax is one of the most common CVC insertion complications, reportedly representing up to 30% of all mechanical adverse events of CVC insertion.We report a case of central venous catheterization in a 35-year-old female patient, developed hydropneumothorax during subclavian vein catheterization.

Case Presentation A 35-year-old Asian female patient with severe lupus nephritis disease and hypertension, admitted to our ED with chieft complaint acute shortness of breath, undergoing hemodialysis through a right subclavian venous catheter.

Then, 8 hours after the catheter is inserted, during dyalisis, the patient developed shortness of breath, right-sided pleuritic chest pain, sudden onset, and gradually progressive in nature. Physical examination revealed absent air entry over the right lung field. A post-procedure chest X-ray showed right sided hydropneumothorax. An emergency intercostal drainage tube was placed in the 5th intercostal space in the right side in the safe triangle. Post chest tube insertion, the patient’s symptoms resolved, and the patient was clinically better, oxygen saturation normalized. A post chest tube insertion, X-ray was taken, and showed tube in position with pneumothorax being resolved and lung expanded. The chest tube was placed for 5 days after  which it was clamped for an observation period of 8 h and the patient had no complaints of dyspnea or chest pain during the observation period. The patient was discharged on day 7 with significant improvement.

Subclavian vein insertion has been reported to have a higher incidence of pneumothorax than IJV insertion.While it is standard practice to obtain a chest X-ray after catheterization to confirm placement and to exclude complication, initial films may fail to show a hydropneumothorax, a delayed pneumothorax may occur from 8 h to 4 days after insertion. A routine practice of taking a post-procedure X-ray immediately after cannulation and monitoring the patient for any symptoms of dyspnea or chest pain should be made mandatory.Furthermore, there are evidence of delayed development of hydropneumothorax post central line insertion, hence, repeat chest X-ray in symptomatic cases should be done even after an initial negative chest X-ray. Pulmonary involvement in SLE is common, pleuritis can occurred in 45 % of patients. In SLE, pleural effusion usually bilateral and small to moderate in size, massive effusion leading to mediastinal shift have also been reported.

  This case highlights the potential for complications during central venous catheter insertion via subclavia vein in in severe lupus nephritis patient.     

 

Kewords